Before Adam Head started as CARTI's president and CEO seven months ago, he knew the cancer treatment organization needed a transfusion.
Want the Full Article?
Get Unlimited Archive Access for $19.95 per Year
Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.
Purchase Now
Already have archive access? Login to view this article.
